|
FY2026
12 months to Jun 30, 2026
|
FY2025
12 months to Jun 30, 2025
|
FY2024
12 months to Jun 30, 2024
|
FY2023
12 months to Jun 30, 2023
|
FY2022
12 months to Jun 30, 2022
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Stock-based compensation | |||||
| Impairment charges for leases and leasehold improvements | |||||
| Deferred income taxes | |||||
| Gain on a non-cash sale of a controlling interest of a subsidiary | |||||
| Amortization of interest rate swap contracts | |||||
| Net loss on exchange derivative and capped call transactions | |||||
| Amortization of debt discount and issuance cost | |||||
| Net loss (gain) on strategic investments | |||||
| Net foreign currency loss (gain) | |||||
| Other | |||||
| Changes in operating assets and liabilities, net of business combinations: | |||||
| Accounts receivable, net | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable | |||||
| Accrued expenses and other liabilities | |||||
| Deferred revenue | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Business combinations, net of cash acquired | |||||
| Purchases of intangible assets | |||||
| Purchases of property and equipment | |||||
| Purchases of strategic investments | |||||
| Purchases of marketable securities | |||||
| Proceeds from maturities of marketable securities | |||||
| Proceeds from sales of marketable securities | |||||
| Proceeds from sales of strategic investments | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from Term Loan Facility | |||||
| Repayment of Term Loan | |||||
| Repayment of exchangeable senior notes | |||||
| Proceeds from settlement of capped call transactions | |||||
| Repurchases of Class A Common Stock | |||||
| Other | |||||
| Net cash used in financing activities | |||||
| Effect of foreign exchange rate changes on cash and cash equivalents | |||||
| Net increase (decrease) in cash, cash equivalents, and restricted cash | |||||
| Cash, cash equivalents, and restricted cash at beginning of period | |||||
| Net decrease in cash and cash equivalents included in assets held for sale | |||||
| Cash, cash equivalents, and restricted cash at end of period | |||||
| Supplemental disclosures of cash flow information: | |||||
| Income taxes paid, net of refunds | |||||
| Interest paid | |||||
| Received from interest rate swap contracts | |||||
| Non-cash investing and financing activities: | |||||
| Purchase of property and equipment included in accrued expenses and other liabilities | |||||
| Repurchases of Class A Common Stock and related excise tax liability included in accrued expenses and other current liabilities | |||||
| Debt issuance costs included in accrued expenses and other current liabilities | |||||
| Reconciliation of cash, cash equivalents, and restricted cash within the consolidated balance sheets to the amounts shown in the consolidated statements of cash flows above: | |||||
| Cash and cash equivalents | |||||
| Restricted cash included in other non-current assets | |||||
Loading...